CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2014 it was $324.15K.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $324.15K | – |
See a number that looks wrong?